CalciMedica announces annual shareholder meeting
CALC•Reverse split and warrant-related proposals
Stockholders will also vote on a reverse stock split in a 1-for-2 to 1-for-10 range with a proportional cut in authorized shares.
Other votes cover issuing Series A Warrants and Series B Warrants for up to 18,673,429 shares each, plus related share issuance.
A separate proposal addresses warrant-related issuance tied to directors and officers for up to 1,680,565 shares for each warrant series.
Annual stockholder meeting set for Aug. 19, 2026
CalciMedica will hold its annual stockholder meeting virtually on Aug. 19, 2026.
Items include electing two Class III directors, approving changes to the 2023 equity incentive plan, and an advisory vote on executive pay.
